Tribute Pharmaceuticals Private Limited - Company Profile

It is a chemicals private limited company based in Hyderabad-34., Telangana, India, established in 1995.
1995 Hyderabad-34., Telangana, India Struck Off
Last Updated:
Access Report
About Tribute Pharmaceuticals Private Limited

Tribute Pharmaceuticals Private Limited, a struck off private limited company, was established on 18 April 1995 in Hyderabad-34., Telangana, India. Engaging in other chemical product within the chemicals sector, it holds CIN: U24239TG1995PTC040649. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.43 M.

Its leadership includes Sudharani Jasti (Director), Venkateswarlu Jasti (Director). Its latest AGM occurred on 30 September 2009, with the balance sheet filed on 31 March 2009. It is based at Sde Serene Chambers,Road No.7, (New), Banjara Hills,, Hyderabad-34., Telangana.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24239TG1995PTC040649

  • Registration Number

    040649

  • Incorporation Date

    18 April 1995

  • Authorized Capital

    ₹1.00 M

  • Paid-Up Capital

    ₹0.43 M

  • ROC Code

    Roc Hyderabad

  • Listing Status

    Unlisted

  • Company Status

    Struck Off

Key Metrics
  • Authorised Capital ₹ 1.00 M
  • Paid Up Capital ₹ 0.43 M
  • Company Age 30 Year, 9 Months
  • Last Filing with ROC 31 Mar 2009
Company report

Tribute Pharmaceuticals Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Tribute Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Tribute Pharmaceuticals Private Limited?
Current Directors
Name Designation Appointment Date Status
Sudharani Jasti Director 01 Apr 1999 Current
Venkateswarlu Jasti Director 05 Sep 2005 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Tribute Pharmaceuticals.

Enhance accessibility to Tribute Pharmaceuticals's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Tribute Pharmaceuticals revenue growth over time
Tribute Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Tribute Pharmaceuticals?

Unlock access to Tribute Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Tribute Pharmaceuticals?

Unlock and access historical data on people associated with Tribute Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Tribute Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Tribute Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Tribute Pharmaceuticals
Recent Activity within the Organization
  • Annual General Meeting

    Progress on Tribute Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2009 as per latest MCA records. was documented.

  • Balance Sheet

    The activity Tribute Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2009 with Roc Hyderabad. was completed.

  • Director Appointment

    The activity Venkateswarlu Jasti was appointed as a Director was appointed as a Director on 05 Sep 2005 & has been associated with this company since 20 years 5 months . was completed.

  • Director Appointment

    Sudharani Jasti was appointed as a Director was appointed as a Director on 01 Apr 1999 & has been associated with this company since 26 years 10 months . was recorded as a recent event.

  • Company Incorporation

    The activity Tribute Pharmaceuticals Private Limited was registered on 18 Apr 1995 with Roc Hyderabad & aged 30 years 9 months as per MCA records. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Tribute Pharmaceuticals Private Limited?

The CIN of Tribute Pharmaceuticals Private Limited is U24239TG1995PTC040649.

Where is Tribute Pharmaceuticals Private Limited headquartered?

Tribute Pharmaceuticals Private Limited is headquartered at Sde Serene Chambers,Road No.7, (New), Banjara Hills,, Hyderabad-34., Telangana.

When was Tribute Pharmaceuticals Private Limited incorporated?

Tribute Pharmaceuticals Private Limited was incorporated on 18 April 1995.

Who are the current directors of Tribute Pharmaceuticals Private Limited?

The current directors of Tribute Pharmaceuticals Private Limited are

What is the primary industry of Tribute Pharmaceuticals Private Limited?

The primary industry of Tribute Pharmaceuticals Private Limited is Chemicals.

Is Tribute Pharmaceuticals Private Limited a listed company?

Tribute Pharmaceuticals Private Limited is unlisted.

What is the capital structure of Tribute Pharmaceuticals Private Limited?

The authorized capital of Tribute Pharmaceuticals Private Limited is ₹1.00 M, and the paid-up capital is ₹0.43 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available